March 14, 2025 - 02:05

Researchers at Queen Mary University of London have developed a groundbreaking dental treatment aimed at protecting teeth from decay and acid erosion. This innovative approach draws inspiration from advanced civil engineering technology, specifically the techniques used in the maintenance of the iconic Forth Bridge in Scotland.
The new treatment involves a specialized coating that mimics the protective properties of the paint used on the bridge, which is designed to withstand harsh environmental conditions. By applying similar principles to dental care, the researchers have created a solution that not only strengthens tooth enamel but also enhances its resistance to harmful acids produced by bacteria in the mouth.
The implications of this research could be significant, offering a novel way to combat common dental issues that affect millions globally. This development paves the way for more effective preventive measures in dentistry, potentially reducing the need for fillings and other invasive procedures in the future. As this technology advances, it holds promise for improving oral health and overall quality of life.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...